See more : Shenzhen Wenke Landscape Co., Ltd. (002775.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of MPH Health Care AG (0W1Q.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of MPH Health Care AG, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Galimmo SCA (GALIM.PA) Income Statement Analysis – Financial Results
- Norditek Group AB (publ) (NOTEK.ST) Income Statement Analysis – Financial Results
- Bojun Education Company Limited (1758.HK) Income Statement Analysis – Financial Results
- Sundrug Co.,Ltd. (SDGCF) Income Statement Analysis – Financial Results
- Malvern Bancorp, Inc. (MLVF) Income Statement Analysis – Financial Results
MPH Health Care AG (0W1Q.L)
About MPH Health Care AG
MPH Health Care AG, an investment company, engages in the healthcare business in Germany. It produces and sells medicinal products for the therapies of cancer, HIV, and other chronic diseases. The company also offers medical aesthetic treatments; and develops and sells pharmaceutical and medical products; and provides related services, as well as medical devices for the aesthetic surgery and cosmetic dermatology. In addition, it is involved in the provision of cytostatic solutions; and real estate activities. The company was formerly known as MPH Mittelständische Pharma Holding AG and changed its name to MPH Health Care AG in 2017. The company was founded in 2008 and is based in Berlin, Germany. MPH Health Care AG is a subsidiary of Magnum AG.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.24M | 6.85M | 4.36M | -9.02M | 6.31M | 44.85M | 33.81M | 8.89M | 262.89M | 219.25M | 226.84M | 205.71M | 145.52M | 112.41M | 62.22M |
| Cost of Revenue | -118.71M | 45.17K | 347.99K | 434.13K | 341.05K | 732.87K | 0.00 | 17.00K | 236.13M | 197.46M | 210.00M | 181.57M | 128.68M | 94.47M | 51.89M |
| Gross Profit | 125.94M | 6.80M | 4.01M | -9.45M | 5.97M | 44.11M | 33.81M | 8.87M | 26.76M | 21.79M | 16.85M | 24.13M | 16.84M | 17.94M | 10.33M |
| Gross Profit Ratio | 1,740.35% | 99.34% | 92.02% | 104.81% | 94.60% | 98.37% | 100.00% | 99.81% | 10.18% | 9.94% | 7.43% | 11.73% | 11.57% | 15.96% | 16.61% |
| Research & Development | 0.00 | 4.30 | -2.11 | 7.92 | 1.75 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.14M | 987.25K | 923.32K | 841.50K | 933.71K | 1.15M | 1.18M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.14M | 987.25K | 923.32K | 841.50K | 933.71K | 1.15M | 1.18M | 558.00K | 8.33M | 6.48M | 5.82M | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | -24.11M | 22.76M | -13.09M | -61.56M | 5.61M | 29.87M | 23.64M | 71.23M | -727.37K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | -22.97M | -22.76M | 13.09M | 61.56M | -5.61M | 7.20M | 1.52M | 65.21M | 62.52M | 10.88M | 4.36M | 2.26M | 6.20M | 7.54M | 4.19M |
| Cost & Expenses | -22.97M | -22.71M | 13.44M | 62.00M | -5.26M | 7.20M | 1.52M | 65.23M | 298.65M | 208.34M | 214.36M | 183.83M | 134.88M | 102.02M | 56.07M |
| Interest Income | 135.37K | 80.00K | 80.00K | 75.34K | 14.50K | 299.00K | 167.00K | 7.04M | 2.00M | 1.60M | 1.22M | 224.82K | 3.00K | 3.01K | 663.80 |
| Interest Expense | 576.26K | 169.45K | 194.60K | 509.64K | 540.09K | 506.62K | 498.50K | 770.41K | 2.22M | 1.81M | 1.70M | 1.57M | 798.00K | 288.53K | 299.52K |
| Depreciation & Amortization | 19.11K | 25.17K | 20.08K | 17.04K | 11.23K | 29.95K | 21.37K | 24.83K | 10.90M | 1.83M | 1.72M | 1.08M | 372.30K | 246.80K | 236.12K |
| EBITDA | 30.36M | 29.68M | -9.05M | -71.00M | 40.30M | 37.69M | 33.08M | 79.37M | 14.05M | 12.74M | 14.21M | 23.12M | 11.01M | 10.64M | 6.38M |
| EBITDA Ratio | 419.58% | 431.96% | -207.59% | 787.12% | 183.61% | 97.61% | 97.84% | 156.48% | 5.34% | 5.81% | 6.26% | 11.27% | 7.57% | 9.47% | 10.26% |
| Operating Income | 30.21M | 29.56M | -9.07M | -71.02M | 11.58M | 43.73M | 33.06M | 7.89M | 3.15M | 10.91M | 12.48M | 21.88M | 10.64M | 10.40M | 6.15M |
| Operating Income Ratio | 417.44% | 431.59% | -208.05% | 787.31% | 183.43% | 97.51% | 97.78% | 88.77% | 1.20% | 4.98% | 5.50% | 10.63% | 7.31% | 9.25% | 9.88% |
| Total Other Income/Expenses | -440.89K | -89.45K | -114.60K | -434.31K | -525.59K | -6.39M | -168.00K | 1.81M | 68.85M | -1.60M | 233.00K | -1.41M | -746.00K | -285.52K | -299.88K |
| Income Before Tax | 29.77M | 29.47M | -9.19M | -71.45M | 11.05M | 37.34M | 32.12M | 81.16M | 87.28M | 9.31M | 11.26M | 20.47M | 9.89M | 10.11M | 5.85M |
| Income Before Tax Ratio | 411.35% | 430.28% | -210.68% | 792.13% | 175.10% | 83.27% | 95.00% | 912.89% | 33.20% | 4.25% | 4.96% | 9.95% | 6.80% | 8.99% | 9.40% |
| Income Tax Expense | 223.52K | 358.86K | -232.65K | -1.07M | -26.57K | 317.00K | 264.00K | 1.09M | 3.18M | 856.00K | 3.77M | 2.07M | 1.25M | 981.09K | 768.60K |
| Net Income | 29.54M | 29.11M | -8.96M | -70.38M | 11.08M | 37.02M | 31.86M | 80.07M | 82.59M | 4.95M | 6.45M | 14.71M | 8.64M | 9.13M | 5.08M |
| Net Income Ratio | 408.26% | 425.05% | -205.34% | 780.25% | 175.53% | 82.56% | 94.22% | 900.63% | 31.42% | 2.26% | 2.84% | 7.15% | 5.94% | 8.12% | 8.16% |
| EPS | 6.90 | 6.80 | -2.09 | -16.44 | 2.59 | 8.65 | 7.44 | 18.70 | 19.29 | 1.20 | 1.61 | 3.70 | 2.10 | 2.40 | 1.30 |
| EPS Diluted | 6.90 | 6.80 | -2.09 | -16.44 | 2.59 | 8.65 | 7.44 | 18.70 | 19.29 | 1.20 | 1.61 | 3.70 | 2.10 | 2.40 | 1.30 |
| Weighted Avg Shares Out | 4.28M | 4.28M | 4.28M | 4.28M | 4.28M | 4.28M | 4.28M | 4.28M | 4.28M | 4.13M | 3.86M | 3.93M | 4.12M | 3.81M | 3.81M |
| Weighted Avg Shares Out (Dil) | 4.28M | 4.28M | 4.28M | 4.28M | 4.28M | 4.28M | 4.28M | 4.28M | 4.28M | 4.13M | 4.01M | 3.93M | 4.12M | 3.81M | 3.81M |
Source: https://incomestatements.info
Category: Stock Reports